<DOC>
	<DOCNO>NCT02945826</DOCNO>
	<brief_summary>The purpose study investigate applicability urokinase plasminogen activator receptor ( uPAR ) Positron Emission Tomography ( PET ) / MRI molecular imaging glioblastoma .</brief_summary>
	<brief_title>uPAR-PET/MRI Glioblastoma Multiforme</brief_title>
	<detailed_description>68Ga-NOTA-AE105 radioligand target urokinase plasminogen activator receptor ( uPAR ) , promise image biomarker tumor aggressiveness . 68Ga-NOTA-AE105 PET/MRI apply patient suspected glioblastoma multiforme . The uptake radioligand 68Ga-NOTA-AE105 compare correlated expression molecular target : uPAR use immunohistochemistry tumor tissue sample obtain routine stereotactic biopsy operation . In addition , semiquantitative uptake ( standard uptake value , SUVs ) 68Ga-NOTA-AE105 tumor tissue correlate overall survival progression free survival</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>Patients image MRI CT suspicious glioblastoma multiforme , patient , refer stereotactic biopsy , chemotherapy surgery The participant must capable understand give full inform write consent age 18 year Pregnancy Lactation/breast feeding Age 85 year old Weight 140 kg Known allergy towards 68GaNOTAAE105</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>urokinase plasminogen activator receptor</keyword>
	<keyword>positron emission tomography</keyword>
	<keyword>glioblastoma multiforme</keyword>
</DOC>